Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
Cardiovascular Research · 05.09.2023 · 119 (11) · 2061-2073
DOI: 10.1093/cvr/cvad079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 18.05.2023. Verfasst von Andreas Edsfeldt und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Cardiovascular Diseases. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Heart and Lung Foundation, Skåne University Hospital.
Abstract (Originalsprache)
Aims
Transforming growth factor-beta (TGF-β) exists in three isoforms TGF-β1, -β2, and -β3. TGF-β1 has been suggested to be important for maintaining plaque stability, yet the role of TGF-β2 and -β3 in atherosclerosis remains to be investigated. This study explores the association of the three isoforms of TGF-β with plaque stability in the human atherosclerotic disease. Methods and results TGF-β1, -β2, and -β3 proteins were quantified in 223 human carotid plaques by immunoassays. Indications for the endarterectomy were: symptomatic carotid plaque with stenosis >70% or without symptoms and >80% stenosis. Plaque mRNA levels were assessed by RNA sequencing. Plaque components and extracellular matrix were measured histologically and biochemically. Matrix metalloproteinases and monocyte chemoattractant protein-1 (MCP-1) was measured with immunoassays. The effect of TGF-β2 on inflammation and protease activity was investigated in vitro using THP-1 and RAW264.7 macrophages. Patients were followed longitudinally for cardiovascular (CV) events. TGF-β2 was the most abundant isoform and was increased at both protein and mRNA levels in asymptomatic plaques. TGF-β2 was the main determinant separating asymptomatic plaques in an Orthogonal Projections to Latent Structures Discriminant Analysis. TGF-β2 correlated positively to features of plaque stability and inversely to markers of plaque vulnerability. TGF-β2 was the only isoform inversely correlated to the matrix-degrading matrix metalloproteinase-9 and inflammation in the plaque tissue. In vitro, TGF-β2 pre-treatment reduced MCP-1 gene and protein levels as well as matrix metalloproteinase-9 gene levels and activity. Patients with plaques with high TGF-β2 levels had a lower risk to suffer from future CV events.
Conclusions
TGF-β2 is the most abundant TGF-β isoform in human plaques and may maintain plaque stability by decreasing inflammation and matrix degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
- Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden.
- Department of Cardiology, Skåne University Hospital, Malmö, Sweden.
- Faculty of Health and Society, Malmö University, Malmö, Sweden.
- Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden.
- Department of Clinical Sciences, LUDC Bioinformatics Unit, Malmö, Lund University, Lund, Sweden.
ORCID-Profile: Andreas Edsfeldt, Frank Matthes, Anton Gisterå, Marju Orho-Melander, Jan Nilsson, Isabel Gonçalves
Förderung
- Swedish Research Council
- Swedish Heart and Lung Foundation
- Skåne University Hospital
- Påhlsson Foundation
- Crafoord Foundation
- Swedish Society for Medical Research
- Swedish Society of Medicine
- Lund University Diabetes Centre
Zitieren
APA
Edsfeldt, A., Singh, P., Matthes, F., Tengryd, C., Cavalera, M., Bengtsson, E., Dunér, P., Volkov, P., Karadimou, G., Gisterå, A., Orho-Melander, M., Nilsson, J., Sun, J., & Gonçalves, I. (2023). Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events. Cardiovascular Research, 119(11), 2061-2073. https://doi.org/10.1093/cvr/cvad079
Vancouver
Edsfeldt A, Singh P, Matthes F, Tengryd C, Cavalera M, Bengtsson E, et al. Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events. Cardiovascular Research. 2023;119(11):2061-2073. doi:10.1093/cvr/cvad079
BibTeX
@article{Edsfeldt2023,
author = {Edsfeldt, Andreas and Singh, Pratibha and Matthes, Frank and Tengryd, Christoffer and Cavalera, Michele and Bengtsson, Eva and Dunér, Pontus and Volkov, Petr and Karadimou, Glykeria and Gisterå, Anton and Orho-Melander, Marju and Nilsson, Jan and Sun, Jiangming and Gonçalves, Isabel},
title = {Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {11},
pages = {2061--2073},
doi = {10.1093/cvr/cvad079}
}
EUVIMED